scholarly journals Possible Clinical Significance of Serum Soluble Interleukin-2 Receptor Level in Primary Bone Lymphoma: Two Case Reports

2011 ◽  
Vol 4 (1) ◽  
pp. 125-131 ◽  
Author(s):  
Hiroki Yabe ◽  
Hironori Ueno ◽  
Kensuke Ochi ◽  
Hideo Morioka ◽  
Hiroo Yabe ◽  
...  
Keyword(s):  
Clinical Significance ◽  
Case Reports ◽  
Interleukin 2 ◽  
Primary Bone Lymphoma ◽  
Receptor Level ◽  
Interleukin 2 Receptor ◽  
Soluble Interleukin 2 Receptor ◽  
Primary Bone ◽  
Bone Lymphoma

Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma

2020 ◽  
Vol 61 (9) ◽  
pp. 2113-2121
Author(s):  
Kenji Nozaki ◽  
Hiroyuki Sugahara ◽  
Shuji Ueda ◽  
Jun Ishikawa ◽  
Shigeo Fuji ◽  
...  
Keyword(s):  
Follicular Lymphoma ◽  
Interleukin 2 ◽  
Newly Diagnosed ◽  
Receptor Level ◽  
Interleukin 2 Receptor ◽  
Soluble Interleukin 2 Receptor ◽  
Pretreatment Serum

scholarly journals Primary Bone Lymphoma in Axial Skeleton in a Middle-Aged Female Presented as Recurrent Anemia

2020 ◽  
Vol 13 (1) ◽  
pp. 276-280
Author(s):  
Tala Batia ◽  
Mohamed A. Yassin ◽  
Deena S. Mudawi ◽  
Omnia A. Hamid ◽  
Ahmed M.A. Abdalhadi
Keyword(s):  
Cell Lymphoma ◽  
Case Reports ◽  
B Cell Lymphoma ◽  
Axial Skeleton ◽  
Primary Bone Lymphoma ◽  
Large B Cell Lymphoma ◽  
Pathological Type ◽  
Primary Bone ◽  
Insight Into ◽  
Bone Lymphoma

Primary bone lymphoma (PBL) is a peculiar extranodal presentation of non-Hodgkin’s lymphoma. Primary bone diffuse large B-cell lymphoma (DLBCL) is the most common pathological type, comprising about 80% of PBL. The diagnosis of PBL depends on the combined clinical examination and imaging studies and is confirmed with immunohistochemical examination. Due to the rarity of this disease, more relative studies and case reports are needed to provide insight into this obscure lymphoproliferative malignancy. Here, we report one rare case of primary bone DLBCL involving the axial skeleton in a 37-year-old female.

scholarly journals Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP

Hematology ◽  
2017 ◽  
Vol 22 (9) ◽  
pp. 521-526 ◽  
Author(s):  
Kento Umino ◽  
Shin-ichiro Fujiwara ◽  
Takashi Ikeda ◽  
Yumiko Toda ◽  
Shoko Ito ◽  
...  
Keyword(s):  
Follicular Lymphoma ◽  
Prognostic Value ◽  
Interleukin 2 ◽  
Receptor Level ◽  
Interleukin 2 Receptor ◽  
Soluble Interleukin 2 Receptor

Serum Soluble Interleukin 2 Receptor Level as a Marker of Acute Rejection in Pediatric Kidney Transplant Recipients

Nephron ◽  
2018 ◽  
Vol 139 (1) ◽  
pp. 30-38 ◽  
Author(s):  
Amal M. Hagras ◽  
Doaa M. Salah ◽  
Dina H. Ahmed ◽  
Omnia K. Abd Elaal ◽  
Hany Ahmed Fouad Elghobary ◽  
...  
Keyword(s):  
Acute Rejection ◽  
Kidney Transplant ◽  
Interleukin 2 ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Receptor Level ◽  
Interleukin 2 Receptor ◽  
Soluble Interleukin 2 Receptor

scholarly journals Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy

2019 ◽  
Vol 39 (9) ◽  
pp. 5115-5122
Author(s):  
MASAHIDE YAMAMOTO ◽  
KEISUKE TANAKA ◽  
YOSHIHIRO UMEZAWA ◽  
TOSHIKAGE NAGAO ◽  
SHIGEO TOYOTA ◽  
...  
Keyword(s):  
Follicular Lymphoma ◽  
Management Strategy ◽  
Interleukin 2 ◽  
Initial Management ◽  
Receptor Level ◽  
Interleukin 2 Receptor ◽  
Soluble Interleukin 2 Receptor
Sign in / Sign up

Export Citation Format

Share Document